Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570–80.

Article  CAS  PubMed  Google Scholar 

Tanaka A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol. 2021;27:1–21.

Article  PubMed  Google Scholar 

Lv T, Chen S, Li M, et al. Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36:1423–34.

Article  PubMed  Google Scholar 

Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70:1989–2003.

Article  PubMed  Google Scholar 

Tanaka A, Mori M, Matsumoto K, et al. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res. 2019;49:881–9.

Article  CAS  PubMed  Google Scholar 

Murillo Perez CF, Goet JC, Lammers WJ, et al. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history. Hepatology. 2018;67:1920–30.

Article  CAS  PubMed  Google Scholar 

Harms MH, van Buuren HR, Corpechot C, et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71:357–65.

Article  CAS  PubMed  Google Scholar 

Lu M, Zhou Y, Haller IV, et al. Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment. Clin Gastroenterol Hepatol. 2018;16:1342-50.e1.

Article  PubMed  Google Scholar 

Kim KA, Ki M, Choi HY, et al. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther. 2016;43:154–62.

Article  PubMed  Google Scholar 

Cheol Seong S, Kim Y-Y, Khang Y-H, et al. Data resource profile: the national health information database of the national health insurance service in South Korea. Int J Epidemiol. 2016;46:799–800.

PubMed Central  Google Scholar 

Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280–8.

Article  PubMed  Google Scholar 

Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149–53.

Article  CAS  PubMed  Google Scholar 

Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.

Article  CAS  PubMed  Google Scholar 

Zeng N, Duan W, Chen S, et al. Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis. Hep Intl. 2019;13:788–99.

Article  Google Scholar 

Matsumoto K, Ohfuji S, Abe M, et al. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study. J Gastroenterol. 2022;57:19–29.

Article  PubMed  Google Scholar 

Takamura M, Matsuda Y, Kimura N, et al. Changes in disease characteristics of primary biliary cholangitis: an observational retrospective study from 1982 to 2016. Hepatol Res. 2021;51:166–75.

Article  CAS  PubMed  Google Scholar 

Lleo A, Jepsen P, Morenghi E, et al. Evolving trends in female to male incidence and male mortality of primary biliary cholangitis. Sci Rep. 2016;6:25906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69:394–419.

Article  PubMed  Google Scholar 

Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63:930–50.

Article  CAS  PubMed  Google Scholar 

Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149:1804-12.e4.

Article  PubMed  Google Scholar 

John BV, Aitcheson G, Schwartz KB, et al. Male sex is associated with higher rates of liver-related mortality in primary biliary cholangitis and cirrhosis. Hepatology. 2021;74:879–91.

Article  CAS  PubMed  Google Scholar 

Carbone M, Mells GF, Pells G, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;144:560-569.e7.

Article  CAS  PubMed  Google Scholar 

Cheung AC, Lammers WJ, Murillo Perez CF, et al. Effects of age and sex of response to ursodeoxycholic acid and transplant-free Survival in patients with primary biliary cholangitis. Clin Gastroenterol Hepatol. 2019;17:2076-84.e2.

Article  CAS  PubMed  Google Scholar 

Roberts SB, Hirschfield GM, Worobetz LJ, et al. Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis. Hepatology. 2022. https://doi.org/10.1002/hep.32426.

Article  PubMed  Google Scholar 

Harada K, Hirohara J, Ueno Y, et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology. 2013;57:1942–9.

Article  Google Scholar 

Natarajan Y, Tansel A, Patel P, et al. Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis. Dig Dis Sci. 2021;66:2439–51.

Article  PubMed  Google Scholar 

Trivedi PJ, Lammers WJ, van Buuren HR, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. 2016;65:321–9.

Article  PubMed  Google Scholar 

Sivakumar M, Gandhi A, Shakweh E, et al. Widespread gaps in the quality of care for primary biliary cholangitis in UK. Frontline Gastroenterol. 2022;13:32–8.

Article  PubMed  Google Scholar 

Allard NL, MacLachlan JH, Dev A, et al. Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes. BMC Gastroenterol. 2020;20:140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HJ, Hann HJ, Hong SN, et al. Incidence and natural course of inflammatory bowel disease in Korea, 2006–2012: a Nationwide population-based study. Inflamm Bowel Dis. 2015;21:623–30.

Article  PubMed  Google Scholar